MEM Discussion, page-655

I have no issue with Kenji putting forward an alternative opinion.

At least he is posting about MEM and actually contributes ideas to the thread (although in the past he did join the Naysayers in their trash talk for a while, but recently he has been posting about MEM).

Having said that, i obviously disagree with his very negative take on MEM. He talks about things like "trading suspensions" for MEM when he has zero evidence of such. He critiques the reputation of the newly hired Director, when IMO, the evidence shows that Marjan Mikal has had some notable successes in his career (as per below attached posts).

Actually the opposite of what Kenji describes looks more likely IMO. MEM just hired a new Director with notable skills in product commercialisation, and they also just completed a promotional tour for Felix in China after recently completing another promotional tour for Felix in Singapore. They have recently started a new trial with the Roxsta device and have confirmed that Roxsta has significant advantages over traditional tools used to measure oxidative stress.....and are still further pursuing R&D progress in this area with Roxsta.

MEM have openly stated that commercial deals are currently in negotiation (as per post below)....and the IVF market in general is looking extremely bullish across the entire globe (below post describes a $450 million dollar deal underway in India, and a bullish market analysis for China is also posted below).

In the recent interview with MEM's Director of Science (link in below posts), John Aitken hints about MEM further developing a deeper pipeline of IVF devices which the market is clearly not even aware of at present (more news on the horizon in this area it seems).

IMO, MEM appear to be strongly building-up......not at all looking like they are winding down.

As per below, and IMO, the evidence points to a positive future MEM.